Latus develops innovative gene therapy candidates that use precision delivery with the goal of improving the lives of patients.

Latus

Amazon

Kiersten Stead

Jang-Ho Cha

Chief Scientific Officer and Chief Marketing Officer

John Connelly

Chief Development Officer

Paiman Peter Ghoroghchian

Great Lakes Companies With Fewer Than 1000 Employees (Top 10K)

Great Lakes Companies With Less Than $1B in Revenue (Top 10K)

Greater Philadelphia Area Companies (Top 10K)

United States Early Stage Companies (Top 10K)

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.

DCVC Bio

Series A - Latus Bio

Philadelphia

Pennsylvania

United States

North America

Latus Bio

Philly daily roundup: Tech walks; Join us at Builders; Latus Bio raises $54M

Latus Bio: Patient-Centric And Product-Oriented Gene Therapy Company Raises $54 Million

Samsung's Life Science Fund invests in Seattle's Latus Bio

Samsung Life Science invests in US biotech firm Latus Bio

Backed by $54M, biotech veterans, Latus targets new gene therapies

Samsung Life Science Fund invests in US gene therapy firm

Latus Bio Raises $54M in Series A Financing

Latus Bio launches with focus on gene therapies for CNS disorders

Sweden

Europe

Taiwan

Asia

Tunisia

Africa

Lithuania

India

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 13, 2024 5:40 AM	ec9f6998
news daily refresh	general	Aug 20, 2024 6:00 PM	894016fe
news processing daily refresh	general	Aug 20, 2024 5:17 PM	2548b150
news impact assignment daily	general	Aug 20, 2024 7:21 PM	6a46c8a1
news processing basic	general	Jul 13, 2024 7:26 AM	06ea265f
company summary	general	Aug 20, 2024 8:21 PM	93ef7c7c
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	bd0c97d8
crunchbase profile	general	Oct 30, 2024 7:33 AM	35ab95a2
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	50f77f2a
peers	general	Jul 13, 2024 5:40 AM	ba96b030
news basic	general	Jul 13, 2024 5:40 AM	d99f31da
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

LATU

COM:LATUSBIO

Latus